Ledger.Open graph →
SEC Form D · Amendment · filed April 8, 2020

Blaze Bioscience, Inc

Offering
$25.2M
Sold
$20.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Mary E. Hughes · Seattle, WADirectorClaudia K. Jochheim · Seattle, WAExecDennis C. Miller · Seattle, WAExecHeather L. Franklin · Seattle, WAExec · DirectorJames C. Towne · Seattle, WADirectorLudmila R. Lobanova · Seattle, WAExecJan K. Ohrstrom · Seattle, WADirectorDuncan Maitland · Santa Clara, CAExecRonald D. Robinson · SCOTTSDALE, AZDirectorKevin P. Mcdowell · SCOTTSDALE, AZExecCantor Fitzgerald, L.P. F. Cantor Fitzgerald, L.P · NEW YORK, NYDirectorJames R. Lawson · SCOTTSDALE, AZExecJacob Kriegel · Austin, TXExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗